German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Launched by JOHANN WOLFGANG GOETHE UNIVERSITY HOSPITAL · Sep 12, 2005
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • T-lymphoblastic lymphoma (bone marrow \[BM\] involvement \< 25%)
- • Aged 15-65 years (55-65 years if biologically younger)
- • Written informed consent
- Exclusion Criteria:
- • Severe complications due to lymphoma or secondary disease
- • T-LBL as second malignancy or other active second malignancy
- • Cytostatic pretreatment of LBL (exception of emergency treatments)
- • Pregnancy
- • Severe psychiatric illness or other circumstances which may compromise cooperation of the patient or informed consent
- • Participation in other study interfering with study treatment
About Johann Wolfgang Goethe University Hospital
Johann Wolfgang Goethe University Hospital, located in Frankfurt am Main, Germany, is a prominent academic medical center affiliated with Goethe University. Renowned for its commitment to advancing healthcare through innovative research and clinical excellence, the hospital serves as a vital hub for clinical trials and medical studies. It integrates cutting-edge technology with a multidisciplinary approach, facilitating collaboration among healthcare professionals to enhance patient outcomes. The hospital is dedicated to ethical research practices and adheres to stringent regulatory standards, ensuring the safety and well-being of trial participants while contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt, , Germany
Patients applied
Trial Officials
Dieter Hoelzer, MD, PhD
Study Chair
University Hospital Frankfurt, Medical Dept. II
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials